Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- The Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease.J Am Med Assoc. 2009; 302: 1993-2000
- ApoB and the atherogenic ApoB dyslipoproteinemias.in: Kwiterovich Jr., P.O. The Johns Hopkins Textbook of Dylipidemia. Lippincott Williams & Wilkins, Philadelphia, PA2009: 196-210
- The relative importance of lipids, lipoproteins, and apolipoproteins as risk markers associated with myocardial infarction in 52 countries.Lancet. 2008; 372: 224-233
- The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls.Eur Heart J. 2009; 30: 2137-2146
- ApoB versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.J Intern Med. 2006; 259: 247-258
NHANES Investigators. NHANES Analytic Guidelines 2003–2004. Available at: http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/nhanes_analytic_guidelines_dec_2005.pdf. Accessed February 16, 2009.
- Prediction of coronary heart disease using risk factor categories.Circulation. 1998; 97: 1837-1847
- Primary and subsequent coronary risk appraisal: new results from the Framingham study.Am Heart J. 2000; 139: 272-281
- Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.N Engl J Med. 2008; 359: 2195-2207
- ApoB versus non-HDLC: What to do when they disagree.Curr Atheroscler Rep. 2009; 11: 358-363
- Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.Lancet. 2009; 373: 1175-1182
- Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein B.J Clin Lipidol. 2007; 1: 256-263
- A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias.Nat Clin Endocrinol Metab. 2008; 4: 608-618
- LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study—Implications for LDL management.J Clin Lipidol. 2007; 1: 583-592